Optionale Produktanalyse
Mit Ihrer Erlaubnis verwenden wir datenschutzfreundliche Analysen, um zu verstehen, welche Recherchewege funktionieren. Wir verwenden weder Werbe-Tracker noch Sitzungsaufzeichnungen. Sie können diese Auswahl in den Einstellungen ändern. Lesen Sie die Datenschutzerklärung.
Alphabet Inc. Class C's published Reduce conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $4.15T | |
|---|---|---|
| Revenue (ttm) | 445.9B | |
| Net income (ttm) | 244.1B | |
| EPS (ttm) | $19.9 | |
| Shares out | 12.2B | |
| P/E (trailing) | 16.1x | |
| P/E (forward) | 22.1x | |
| Dividend | $0.88 (0.27%) | |
| Volume | 17,944,160 | |
| Beta | 1.21 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $257.64B | $282.84B | $307.39B | $350.02B | $402.84B | +11.8% |
| Gross profit | $146.70B | $156.63B | $174.06B | $203.71B | $240.30B | +13.1% |
| Operating income | $78.71B | $74.84B | $84.29B | $112.39B | $129.04B | +13.2% |
| Net income | $76.03B | $59.97B | $73.80B | $100.12B | $132.17B | +14.8% |
| EPS (diluted) | $5.61 | $4.56 | $5.80 | $8.04 | $10.81 | +17.8% |
| EBITDA | $103.52B | $85.16B | $97.97B | $135.39B | $180.70B | +14.9% |
| R&D | $31.56B | $39.50B | $45.43B | $49.33B | $61.09B | +17.9% |
| SG&A | $13.51B | $15.72B | $16.43B | $14.19B | $21.48B | +12.3% |
Recent company headlines from major financial publishers.
If revenue meets expectations, profit and cash must still follow before the enlarged build creates enough value to change the valuation view.
This case strengthens if FY2027 revenue meets expectations and free cash flow improves despite the spending build. It weakens if higher spending keeps absorbing operating cash.
| Ke ↓ / g → | 2.0% | 2.5% | 3.0% | 3.5% | 4.0% |
|---|---|---|---|---|---|
| 7.9% | $343 | $356 | $371 | $390 | $414 |
| 8.9% | $308 | $317 | $327 | $338 | $353 |
| 9.9% | $282 | $288 | $295 | $303 | $312 |
| 10.9% | $261 | $266 | $270 | $276 | $282 |
| 11.9% | $244 | $248 | $251 | $255 | $259 |
Upcoming earnings date and setup when available.
Das Rating, das die veröffentlichte Research-Ausgabe des jeweiligen Monats trug. Ein Rating vergleicht den Kurs zum Analysezeitpunkt mit dem Fair Value; es ist kein Nachweis, ob die Einschätzung zutraf.
| Jahr | Jan | Feb | Mär | Apr | Mai | Jun | Jul | Aug | Sep | Okt | Nov | Dez |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |